Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-β/Smad2/3-mediated epithelial-mesenchymal transition

被引:29
|
作者
Li, Se-Ruo [1 ]
Tan, Zhu-Xia [1 ]
Chen, Yuan-Hua [2 ]
Hu, Biao [1 ]
Zhang, Cheng [2 ]
Wang, Hua [2 ]
Zhao, Hui [1 ]
Xu, De-Xiang [2 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 2, Hefei 230032, Anhui, Peoples R China
[2] Anhui Med Univ, Dept Toxicol, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
Pulmonary fibrosis; Vitamin D deficiency; Epithelial-mesenchymal transition; Bleomycin; Mice; COGNITIVE DECLINE; PATHOGENESIS; INHIBITION; INJURY; RISK;
D O I
10.1186/s12931-019-1232-6
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Our earlier report indicated that active vitamin D3 inhibited epithelial-mesenchymal transition (EMT) in bleomycin (BLM)-induced pulmonary fibrosis. The objective of this study was to further investigate whether vitamin D deficiency exacerbates BLM-induced pulmonary fibrosis. Methods This study consists of two independent experiments. Experiment 1, male mice were fed with vitamin D deficient (VDD) fodder. Experiment 2, Cyp27b1(+/+), Cyp27b1(+/-) and Cyp27b1(-/-) mice were fed with standard diet. For pulmonary fibrosis, mice were intratracheally instilled with a single dose of BLM (1.5 mg/kg). Serum 25(OH) D level was measured. Pulmonary collagen deposition was assessed by Sirius red staining. EMT was measured and transforming growth factor-beta (TGF-beta)/Smad3 signaling was evaluated in the lungs of BLM-treated mice. Results The relative weight of lungs was elevated in BLM-treated mice. Col1 alpha 1 and Col1 alpha 2, two collagen protein genes, were upregulated, and collagen deposition, as determined by Sirius red staining, was observed in the lungs of BLM-treated mice. E-cadherin, an epithelial marker, was downregulated. By contrast, vimentin and alpha-SMA, two EMT markers, were upregulated in the lungs of BLM-treated mice. Pulmonary TGF-beta/Smad3 signaling was activated in BLM-induced lung fibrosis. Further analysis showed that feeding VDD diet, leading to vitamin D deficiency, aggravated elevation of BLM-induced relative lung weight. Moreover, feeding VDD diet aggravated BLM-induced TGF-beta/Smad3 activation and subsequent EMT in the lungs. In addition, feeding VDD diet exacerbated BLM-induced pulmonary fibrosis. Additional experiment showed that Cyp27b1 gene knockout, leading to active vitamin D3 deficiency, exacerbated BLM-induced pulmonary fibrosis. Moreover, Cyp27b1 gene knockout aggravated pulmonary TGF-beta/Smad2/3 activation and subsequent EMT in BLM-induced lung fibrosis. Conclusion Vitamin D deficiency exacerbates BLM-induced pulmonary fibrosis partially through aggravating TGF-beta/Smad2/3-mediated EMT in the lungs.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Polyporus Polysaccharide Ameliorates Bleomycin-Induced Pulmonary Fibrosis by Suppressing Myofibroblast Differentiation via TGF-β/Smad2/3 Pathway
    Jiang, Jintao
    Wang, Fang
    Luo, Aishu
    Lin, Shiyu
    Feng, Xiaoke
    Yan, Wei
    Shi, Yumeng
    Zhang, Qian
    Gu, Xin
    Cui, Guoliang
    Wang, Jianan
    Wang, Lei
    Zhang, Qiande
    Tan, Wenfeng
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [22] Vincamine Ameliorates Epithelial-Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis in Rats; Targeting TGF-β/MAPK/Snai1 Pathway
    Alaaeldin, Rania
    Mohyeldin, Reham H.
    Bekhit, Amany Abdlrehim
    Gomaa, Wafaey
    Zhao, Qing-Li
    Fathy, Moustafa
    MOLECULES, 2023, 28 (12):
  • [23] Resveratrol alleviates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition and down-regulating TLR4/NF-ΚB and TGF-β1/smad3 signalling pathways in rats
    Wang, Lei
    Shao, Mei
    Jiang, Wei
    Huang, Yangfeng
    TISSUE & CELL, 2022, 79
  • [24] GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGF β1/Smad-Mediated Epithelial-to-Mesenchymal Transition
    Zhou, Xiao-Ming
    Wang, Gui-Liang
    Wang, Xiao-Bo
    Liu, Li
    Zhang, Qin
    Yin, Yan
    Wang, Qiu-Yue
    Kang, Jian
    Hou, Gang
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [25] Vasoactive intestinal peptide attenuates bleomycin-induced murine pulmonary fibrosis by inhibiting epithelial-mesenchymal transition: Restoring autophagy in alveolar epithelial cells
    Duan, Jia-Xi
    Guan, Xin-Xin
    Yang, Hui-Hui
    Mei, Wen-Xiu
    Chen, Ping
    Tao, Jia-Hao
    Li, Qing
    Zhou, Yong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 101
  • [26] Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway
    Jia, Li
    Sun, Ping
    Gao, Hui
    Shen, Jie
    Gao, Yuan
    Meng, Cheng
    Fu, Shidong
    Yao, Huijuan
    Zhang, Gong
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2019, 71 (06) : 1017 - 1028
  • [27] Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation
    Guan, Ruijuan
    Wang, Xia
    Zhao, Xiaomei
    Song, Nana
    Zhu, Jimin
    Wang, Jijiang
    Wang, Jin
    Xia, Chunmei
    Chen, Yonghua
    Zhu, Danian
    Shen, Linlin
    SCIENTIFIC REPORTS, 2016, 6
  • [28] Low-molecular-weight fucoidan attenuates bleomycin-induced pulmonary fibrosis: possible role in inhibiting TGF-β1-induced epithelial-mesenchymal transition through ERK pathway
    Wang, Lu
    Zhang, Pan
    Li, Xinpeng
    Zhang, Yi
    Zhan, Qingyuan
    Wang, Chen
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (04): : 2590 - 2602
  • [29] Wenfei Buqi Tongluo Formula Against Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β/Smad3 Pathway
    Ding, Lu
    Li, Yaxin
    Yang, Yingying
    Song, Siyu
    Qi, Hongyu
    Wang, Jing
    Wang, Ziyuan
    Zhao, Jiachao
    Zhang, Wei
    Zhao, Linhua
    Zhao, Daqing
    Li, Xiangyan
    Wang, Zeyu
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [30] Tangeretin attenuates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via the PI3K/Akt pathway
    Li, Jiang
    Wei, Qian
    Song, Ke
    Wang, Youxin
    Yang, Yuxin
    Li, Miao
    Yu, Jiaying
    Su, Guangxu
    Peng, Luyuan
    Fu, Bendong
    Yi, Pengfei
    FRONTIERS IN PHARMACOLOGY, 2023, 14